{"id":"W1963505416","doi":"10.1002/hep.26275","title":"JUMP-C: A Randomized Trial of Mericitabine Plus Pegylated Interferon Alpha-2a/Ribavirin for 24 Weeks in Treatment-NaÏVe HCV Genotype 1/4 Patients","year":2013,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Ribavirin; Medicine; Internal medicine; Gastroenterology; Placebo; Hepatitis C virus; Pegylated interferon; Randomized controlled trial; Hepatitis C; NS5B; Alpha interferon; Confidence interval; Hepacivirus; Interferon; Immunology; Virus; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004355038,0.000313225,0.001981999,0.0005174525,0.00004062499,0.00001174609,0.0001716334,0.0003213049,0.0008574532],"category_scores_gemma":[0.001443701,0.0002432039,0.0003241423,0.0003381166,0.0002922021,0.000100065,0.00008248087,0.0002425284,0.0002220249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000452598,"about_ca_system_score_gemma":0.0003617217,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006998903,"about_ca_topic_score_gemma":0.0008784344,"domain_scores_codex":[0.996863,0.0005697485,0.001103265,0.0004815434,0.0003051834,0.0006772725],"domain_scores_gemma":[0.9978262,0.0008510993,0.000248783,0.000458039,0.0004129306,0.0002029509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9006836,0.001621338,0.04967711,0.0001462392,0.0004767897,0.00004372432,0.0008567535,0.000002041857,0.001654911,0.0001376557,0.001944617,0.0427552],"study_design_scores_gemma":[0.968677,0.00988475,0.001417474,0.00006219027,0.0001851905,0.000006083725,0.0000364374,0.01319749,0.001818573,0.0002343989,0.004265014,0.0002153363],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878184,0.0002356423,0.0002302725,0.0008901461,0.0005359823,0.008342072,0.00004479471,0.00004953067,0.001853121],"genre_scores_gemma":[0.9952562,0.0003120483,0.0006429465,0.0001616946,0.00008826309,0.002149092,0.0002579607,0.00005877523,0.001072991],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06799345,"threshold_uncertainty_score":0.9996136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03793468779822394,"score_gpt":0.3338384834654721,"score_spread":0.2959037956672482,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}